Latest Articles

Publication Date
All News Scientific
Natural Procreative Technology (NaProTechnology) for infertility: take-home baby rate and clinical outcomes in a 5-year single-center cohort of 1,310 couples - Frontiers

Natural Procreative Technology (NaProTechnology) for infertility: take-home baby rate and clinical outcomes in a 5-year single-center cohort of 1,310 couples Frontiers

Published: Oct. 28, 2025, 5:06 p.m.
Read Full Article
Navigating Tumour Microenvironment in Endometrial Carcinoma: A Comprehensive Review Integrating Immunohistochemistry, Single-cell RNA-sequencing and Spatial Transcriptomics - Frontiers

Navigating Tumour Microenvironment in Endometrial Carcinoma: A Comprehensive Review Integrating Immunohistochemistry, Single-cell RNA-sequencing and Spatial Transcriptomics Frontiers

Published: Oct. 28, 2025, 4:44 p.m.
Read Full Article
Risk factors for postoperative recurrence of deep infiltrating endometriosis during a 6- to 12-year follow-up - Nature

Risk factors for postoperative recurrence of deep infiltrating endometriosis during a 6- to 12-year follow-up Nature

Published: Oct. 28, 2025, 8:59 a.m.
Read Full Article
CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer - BioSpace

CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer BioSpace

Published: Oct. 28, 2025, 5:03 a.m.
Read Full Article
CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer - The AI Journal

CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer The AI Journal

Published: Oct. 27, 2025, 7:50 p.m.
Read Full Article
CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer - Yahoo Finance

CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer Yahoo Finance

Published: Oct. 27, 2025, 7:33 p.m.
Read Full Article
CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer - Business Wire

CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer Business Wire

Published: Oct. 27, 2025, 7:33 p.m.
Read Full Article
Mechanism of action of HuPoSan on EMs rats as revealed by multi-omics combined with network pharmacology - ScienceDirect.com

Mechanism of action of HuPoSan on EMs rats as revealed by multi-omics combined with network pharmacology ScienceDirect.com

Published: Oct. 27, 2025, 6 a.m.
Read Full Article
Rate of GP-diagnosed endometriosis rises 60% in 10 years: Aussie study - AusDoc

Rate of GP-diagnosed endometriosis rises 60% in 10 years: Aussie study AusDoc

Published: Oct. 27, 2025, 3:04 a.m.
Read Full Article
Minister for Health Announces Accelerated Clinical Pathway in New Endometriosis Framework for Sufferers - Emegypt

Minister for Health Announces Accelerated Clinical Pathway in New Endometriosis Framework for Sufferers Emegypt

Published: Oct. 26, 2025, 6:53 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!